Velvet Therapeutics
PrivateLast Round
VC Round
Sep 18, 2023
Total Funding Raised
$1.62M
Company Overview
Velvet Therapeutics is a biotechnology company developing gene therapies intended to treat rare cancers and autoimmune diseases using a proprietary non-viral, in vivo CAR platform.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Velvet Therapeutics Comparables
Compare Velvet Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Aera Therapeutics | 86% | |
| Ensoma | 79% | |
| Eli Lilly and Company | 78% |
Velvet Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| VC Round | Sep 18, 2023 | ||||
| Debt | Aug 28, 2023 | ||||
| Seed | Jan 11, 2021 |
Velvet Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| BCM Ventures | VC Round, Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Sep 18, 2023
Raised $2M from BCM Ventures.
- Aug 28, 2023
$500K debt round completed.
Velvet Therapeutics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Velvet Therapeutics's valuation, stock price, and market status.
Is Velvet Therapeutics a public or private company?
Velvet Therapeutics is a private company.
What is the current stock price of Velvet Therapeutics?
Velvet Therapeutics is a private company with no public stock price. No recent secondary market data is available.
How much is Velvet Therapeutics worth (valuation)?
Valuation information for Velvet Therapeutics is not publicly available.
Can I buy Velvet Therapeutics stock?
Velvet Therapeutics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Velvet Therapeutics's last funding round?
Velvet Therapeutics's most recent funding round was VC Round on September 18, 2023.
Who are the main investors in Velvet Therapeutics?
Key investors in Velvet Therapeutics include BCM Ventures.
Will Velvet Therapeutics IPO soon?
No public IPO plans have been announced for Velvet Therapeutics.
How can I track Velvet Therapeutics secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Velvet Therapeutics's secondary market activity and sign up for updates.